Daiwa Securities Group Inc. - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 231 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$07200.0%0.00%
Q2 2023$0
-100.0%
720
-98.2%
0.00%
Q1 2023$33
-34.0%
39,877
+23.9%
0.00%
Q4 2022$50
-99.9%
32,186
-20.1%
0.00%
-100.0%
Q3 2022$69,000
-22.5%
40,273
-22.0%
0.00%0.0%
Q2 2022$89,000
+18.7%
51,629
+146.6%
0.00%
Q1 2022$75,000
+2.7%
20,935
+43.5%
0.00%
Q4 2021$73,000
+35.2%
14,590
+92.3%
0.00%
Q3 2021$54,000
+1250.0%
7,589
+1755.5%
0.00%
Q2 2021$4,0000.0%4090.0%0.00%
Q1 2021$4,000
+33.3%
409
+28.2%
0.00%
Q4 2020$3,000
-70.0%
319
-64.7%
0.00%
Q3 2020$10,000
+150.0%
904
+60.3%
0.00%
Q2 2020$4,0000.0%5640.0%0.00%
Q1 2020$4,000
+100.0%
564
+13.0%
0.00%
Q4 2019$2,000
+100.0%
4990.0%0.00%
Q3 2019$1,0000.0%4990.0%0.00%
Q2 2019$1,000
-50.0%
4990.0%0.00%
Q1 2019$2,0000.0%4990.0%0.00%
Q4 2018$2,000
-33.3%
4990.0%0.00%
Q3 2018$3,000
+50.0%
4990.0%0.00%
Q2 2018$2,0000.0%4990.0%0.00%
Q1 2018$2,0004990.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
CAXTON ASSOCIATES LP 784,679$643,4370.10%
Green Alpha Advisors, LLC 146,300$119,9660.08%
Virtus ETF Advisers LLC 54,106$44,3670.02%
Cedar Brook Financial Partners, LLC 104,881$86,0020.02%
PROFUND ADVISORS LLC 418,749$343,3740.02%
Arlington Capital Management, Inc. 27,735$22,7430.02%
Hennion & Walsh Asset Management, Inc. 382,158$3130.02%
Rafferty Asset Management, LLC 2,647,927$2,171,3000.02%
Brainard Capital Management LLC 16,666$13,6660.01%
Beck Bode, LLC 41,218$33,7990.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders